Trending Now
We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
{{ subpage.title }}
What We’re Watching: SCOTUS mulling student debt relief, Blinken visiting Central Asia, Biden's partial TikTok ban, Petro’s post-honeymoon phase
US Supreme Court weighs student loan forgiveness
The US Supreme Court began hearing arguments on Tuesday in a pair of cases that will test the limitations of presidential power and could derail Joe Biden’s plan to forgive $400 billion in student debt. Biden campaigned on debt relief, promising to help families burdened by the pandemic-fueled economic crisis. But now the court will decide whether Biden has the authority to forgive student loans. The White House cites a 2003 law aimed at alleviating hardship suffered by federal student loan recipients following a national emergency, but opponents say debt relief should require congressional approval. Biden hopes to fulfill his campaign promise ahead of next year’s presidential race, and millions of millennials and Gen-Z scholars – many of whom could see up to $20,000 of their federal student loan debt wiped away – will be waiting with bated breath. A decision will drop before the court adjourns in June, but so far, justices in the conservative majority seem critical of Biden’s move.
Blinken’s trip to Central Asia
US Secretary of State Antony Blinken on Tuesday met with foreign ministers from five former Soviet Republics: Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, and Turkmenistan. Blinken wants to signal solidarity with Russia’s neighbors and try to ensure that trade routes in these countries are not used by Russia to evade Western sanctions. The 'Stans are happy for the support because they have all felt pressure from Moscow to form closer ties with Russia. In particular, Putin has pressed Kazakhstan’s President Kassym-Jomart Tokayev, without success, to support Russia’s war in Ukraine. Tokayev has a reason for concern: Putin has cited the defense of persecuted ethnic Russians in Ukraine as a motive for his war, and Kazakhstan is home to the second-largest population of ethnic Russians among former Soviet Republics. These states, faced with varying degrees of economic trouble exacerbated by the food and fuel inflation that followed the invasion of Ukraine, could also use some direct US help. During the visit, Blinken announced $25 million of new funding to support economic growth in the region in addition to $25 million the Biden administration had already pledged.
Will China respond to Biden’s government TikTok ban?
China hit back at the US on Tuesday for joining the European Union in banning TikTok from government devices. China’s foreign ministry said that Washington’s move – which gives government employees 30 days to remove the social app from their phones – is an abuse of “state power.” Canada, for its part, followed up with a similar ban. These developments come amid fears that the app, owned by Chinese company ByteDance but based in Singapore, is being used by China’s Communist Party to gather government data. Will Beijing retaliate? Anna Ashton, a China expert at Eurasia Group, thinks any significant reprisal by Beijing for a partial or even a full TikTok ban in the US is unlikely. “It isn’t clear that Beijing will bear any significant loss if TikTok stops operating in the United States, nor is it clear that there would be any real gain in lashing out over such a ban,” she says, noting that there was no clear retaliation from Beijing when India banned TikTok a few years back. What’s more, Ashton says, “TikTok is a private company, and social media companies (much like online sales platforms) are not strategic priorities in China’s technological development plans.” Meanwhile, Congress will proceed on Wednesday to further a bill that would allow the Biden administration to ban TikTok for America’s 100 million users. Being tough on China is a rare bipartisan policy issue. Still, it’s unclear whether the Democratic-controlled Senate will back the GOP-sponsored legislation.
First cabinet reshuffle in Petro’s Colombia
A clash over healthcare and education reforms has provoked the first reshuffle of Colombian President Gustavo Petro’s government since he took power last August. The left-wing leader’s plans to expand the government’s role in both sectors drew a public backlash from several of his more centrist cabinet officials. Among them was Education Minister Alejandro Gaviria, whom Petro promptly sacked along with the ministers of sport and culture. Petro – a notoriously headstrong former guerilla – was elected on a change platform, but at the outset of his term, he brought in centrist allies to quell fears that he’d govern as a wild-eyed revolutionary. Now, as his honeymoon period melts away, is this reshuffle simply a necessary move to preserve policy unity, or is he starting to show his true colors?COVID upended the job market & focused employers on skills
COVID had few silver linings. But perhaps one of them is that it upended the labor market in ways that, for once, favored workers over employers.
The switch to virtual meant that recruiters were forced to urgently find people with the right digital skills instead of waiting for those that had gone to the "right" schools.
"The talent market became a little dry," Jonathan Rochelle, VP of Product Management, Learning Content & Instructor Experience at Linkedin, says during a Global Stage livestream discussion.
LinkedIn data, he adds, shows that the trend continues to grow.
Watch the full Global Stage discussion, live from the 77th UN General Assembly.
Coronavirus vs monkeypox
The reigning pandemic champs aren't happy about this upstart challenger -- but maybe there's a deal to be made?
Watch more PUPPET REGIME!
Subscribe to GZERO Media's YouTube channel to get notifications when new videos are published.
The Ugly Politics of COVID-19's Birth
China’s COVID-19 coverup continues. Earlier today (July 22), Chinese officials firmly rejected a request by the World Health Organization (WHO) to grant access to laboratories in the area the novel coronavirus was first identified. China’s deputy health minister says the request shows “disrespect for common sense and arrogance toward science.” Beijing did allow WHO investigators to visit the city of Wuhan back in January, but its bureaucrats say there’s no need to investigate labs, because Chinese authorities have already ruled them out as a source of the virus.
When future historians write about COVID-19 and this global pandemic, they’ll lead with the losses—human and economic. The number of dead. The economic toll. The debts incurred. The lasting damage.
But they’ll have to start the story from the beginning. Where exactly did COVID-19 come from? Most people around the world accept that it came from China, but was it the result of an animal biting a human, an accident for whom no one in power is directly responsible? Or did the virus escape from a research lab, casting blame squarely on the Chinese government for hiding the truth?
We don’t know. We’ll probably never know, because Chinese authorities, those who might be able to answer these questions, aren’t credible and won't give outsiders full access to study the evidence.
Want to understand the world a little better? Subscribe to GZERO Daily by Ian Bremmer for free and get new posts delivered to your inbox every week.
Even if we can’t track the origin of the virus, we can trace the coverup. On December 27, 2019, a doctor in China’s Hubei province reported to local authorities that he’d encountered a disease with dangerous respiratory symptoms. Doctors in Wuhan, Hubei’s largest city, began discussing their fears on social media. After monitoring their conversation, China’s public security service summoned Dr. Li Wenliang and accused him of “making false comments” and disturbing social order. They then arrested others for “spreading rumors.” Dr. Li later became one of COVID-19’s first casualties.
When a Chinese scientist sequenced the coronavirus’ genome on January 5, 2020, Beijing blocked him from publishing his finding. It was an Australian scientist who arranged for online publication of the genome on January 11 after receiving it secretly from a Chinese colleague. Today, experts accuse China of continuing to frustrate the ability of the WHO, and everyone else, to get at the truth.
COVID-19 and the global emergency its variants continue to create leave world leaders with a problem: How to demand accountability from the authoritarian government of one of the world’s most powerful countries (not to mention commercial partner), one which sees secrecy as essential to survival?
The Biden administration has made its choice. The new US president has called for a full investigation into the so-called "Lab Leak Theory," which posits that the negligence of Chinese scientists accidentally unleashed COVID-19 on the world. Washington’s line isn’t surprising. It comes at a time of US-China trade and technology wars. President Biden has continued the more confrontational approach toward Beijing advanced by former President Trump. Biden’s lead Asia advisor says the “era of engagement” with China is over. Competition is now the norm, and the risk of conflict, in various forms, is on the rise.
European leaders are none too happy with Beijing either. “The world has the right to know exactly what happened in order to be able to learn the lessons," said European Council head Charles Michel in early June. An EU-US summit then called for “progress on a transparent, evidence-based and expert-led WHO-convened phase 2 study on the origins of COVID-19, that is free from interference.”
Beijing’s credibility is even taking a hit in countries that are far more dependent on good economic relations with China. More than 90 countries are using vaccines created by Sinopharm and Sinovac Biotech, China’s vaccine makers. The New York Times reported in June that though Chile, Mongolia, Bahrain, and the Seychelles have inoculated higher percentages of their populations than the United States, these four countries on the list of top ten worst current COVID-19 outbreaks in the world. That’s why the dozens of countries that have depended on Chinese-made jabs are worried that COVID-19 variants may kill a lot more their people and force many more lockdowns in coming months.
There’s little the US and Europe can do to force China to become more transparent. Smaller countries, increasingly dependent on good commercial relations with China, have even less leverage. We know that China is unlikely to become less secretive whenever its leaders believe the ruling party’s image and their hold on power face a serious threat.
But we also know that COVID-19 isn’t the last novel coronavirus we’ll see. For all its ongoing damage, COVID-19 was much more infectious but less deadly than severe acute respiratory syndrome (2003), Avian Influenza strains like H7N9 (2013) and H5N1 (2014) and Middle East Respiratory Syndrome (2019). Combine the transmissibility of COVID-19 with the lethality of any of those other viruses, and the next pandemic would be far worse than the one we’re battling now.
The pandemic has surely taught China’s leaders a valuable lesson. Whether they’ll ever admit it publicly, they must know that, with help from the WHO, they could have done much more to contain this virus in those first few dangerous days. Their international reputation would have taken a short-term hit that would now be long forgotten by most of the world’s people. Compare that with the hit China is taking.
🔔 And if you haven't already, don't forget to subscribe to my free newsletter, GZERO Daily by Ian Bremmer, to get new posts delivered to your inbox.
COVID ain't over
We're not done with the pandemic — yet.
In the US, infections are up five-fold from a year ago, although both hospitalizations are down.
Although COVID will likely become endemic sometime this year in some parts of the world, the virus will still rage on everywhere else.
China's zero-COVID strategy is having a tremendous cost, while barely 17.4% of Africans are vaccinated. That bodes well for new variants.
Meanwhile, rich countries keep hoarding jabs, now also against monkeypox. Did we not learn anything after more than two years?
Watch the GZERO World episode: How depoliticizing the US health response will save lives (COVID isn't over)
- Top Risks 2022: We're done with the pandemic, but the pandemic ... ›
- Let's learn from COVID to prevent the next pandemic - GZERO Media ›
- Is omicron the best thing that's happened since the pandemic started ... ›
- How depoliticizing the US health response will save lives (COVID ... ›
- Silicon Valley Bank Collapse: Not 2008 all over again - GZERO Media ›
COVID-19 holiday update: The latest on the Omicron variant
Daily coronavirus infections in the US reached an all-time high this week, with nearly 484,377 confirmed new cases on Wednesday alone. Several European countries including the UK, France, Italy, and Spain are also setting pandemic records. Public health officials are blaming the sharp spike in cases on the rapidly spreading Omicron variant.
The last time I wrote about Omicron was on December 3, only weeks after the strain was first discovered in South Africa. There was a lot we didn't know about the new variant back then, but tons of new data has come out since.
To get you a lowdown on this latest stage of the pandemic, I sat down with Eurasia Group's top public health expert, Scott Rosenstein. Our conversation (lightly edited for clarity) is below.
Omicron first crossed our radar in late November. At the time, we heard “in two weeks we will know more,” and it’s now been about four weeks. Do we know more?
Yes we do. Particularly for two out of the three big questions (transmissibility, vaccines, severity).
On transmissibility, we know that Omicron is spreading really fast. In South Africa, the case curve had a steeper upward slope than any of that country’s previous waves. But there wasn’t a lot of Delta (or any other variant) around during that outbreak, so it was hard to tell what Omicron would do when it faced off against Delta.
Want to understand the world a little better? Subscribe to GZERO Daily by Ian Bremmer for free and get new posts delivered to your inbox every week.
Now we know. Omicron is quickly outcompeting Delta in North America, Europe, and likely many other parts of the world in the coming weeks.
On vaccines, what was once an expectations-defying story has been downgraded to just a very good story. If you think back to 2020 B.V. (Before Vaccines), you may remember that many experts said the best we could really hope for was a vaccine that greatly reduced the risk of severe illness and death. Stopping asymptomatic or mild infections was considered unlikely. Then the mRNA trial data was released, those vaccines were rolled out in a number of countries, and the vaccines not only reduced the risk of going to the hospital, but they also prevented people from getting infected and transmitting the virus to others.
In moderately vaccinated countries, cases plummeted alongside hospitalizations and deaths—until they didn’t. As time went on, protection from severe illness remained high while more mild breakthrough cases started to emerge—first with Delta, and now much more so with Omicron.
So the vaccines are still doing what we hoped they would do in 2020, but that early 2021 vaccine euphoria is getting dampened—a lot of vaccinated people are testing positive, typically with mild illness. And higher risk people (the elderly, the immunocompromised, those with underlying conditions) that have been vaccinated are still sometimes getting severely ill (albeit less frequently than before). Most concerningly, Omicron is incredibly good at finding unvaccinated people, so even in moderately- to highly-vaccinated places, the risk of overwhelmed hospitals remains elevated.
But isn’t Omicron causing more mild illness?
The question around illness severity for Omicron remains the trickiest and most contentious. But we do know more than we did a few weeks ago. The news is relatively positive but still a little difficult to parse.
From lab studies, there is evidence that Omicron isn’t as good as previous variants at replicating in the lungs, where severe illness is more likely to occur. And from real-world data, we can be pretty sure that South Africa’s Omicron outbreak is causing less hospital strain and fewer deaths than previous spikes did. There are some positive signals coming out of the UK as well, but it is earlier days there, and the hospitals are already strained due to widespread Delta transmission.
But the oft-repeated caveat still stands: “A small portion of a very large number is a large number.” In other words, Omicron is spreading far and wide and causing at least some severe illness and death, suggesting that a raging outbreak that spreads faster than ever could still put a serious strain on hospitals in the coming weeks, particularly if the most optimistic scenarios are overstated and Omicron hits healthcare workers already pushed to the brink.
And it is still difficult to ascertain whether the positive real-world data is due primarily to more people having protection from vaccination and/or recent infection, or to the variant being “intrinsically” less severe than its predecessors and therefore less of a risk to the immunologically naïve (i.e., people who haven’t been infected or vaccinated). The answer to this question is not merely academic—if this variant is as dangerous for the unvaccinated and uninfected, the damage around the world could be severe, particularly in developing countries with little ability to cushion the economic blow of more outbreaks and restrictions.
Can you at least tell me when this wave will end?
This variant seems to be on a super-charged timeline, as the time from infection to symptoms and transmission seems faster than previous waves. In South Africa, just as the way up was very fast, so was the way down. And it’s possible we will see something similar in Europe and the US. But it’s unlikely it will all happen in tandem.
Importantly, more bumps in the road aren’t out of the question—the most concerning of which is the record-setting level of pediatric hospitalizations we’re seeing in parts of the US. Headlines around this story are definitely troubling: if this virus turns out to be hitting children harder than before, that would be a gamechanger.
Of course, context is important. Some of these trends started before Omicron, and hospitalizations are still overwhelmingly in unvaccinated children. So it may just be evidence that this outbreak is larger than ever in this group due to the resumption of pre-pandemic behavior. In other words, risks for children may be the same and still considerably lower than for adults, but the outbreak is now so large amongst this mostly-unvaccinated cohort that we’re going to see spikes in hospitalizations like we’ve never seen before.
Regardless, we’re seeing unprecedented case numbers across all age groups, and record-setting holiday travel suggests this pattern isn’t going to reverse itself just yet—even if that isn’t always reflected in official numbers due to testing shortages in places like the US.
What about the new treatments we keep hearing about? Could those put a definitive end to this nightmare?
Help is certainly on the way in the form of more treatments that are easier to administer than previous treatments like Remdesivir and monoclonal antibodies. Paxlovid from Pfizer remains the best hope for cases that are identified early, which adds even more urgency to solving the current testing shortages in the US.
Supply will be limited in the coming weeks so we probably won’t see these treatments make a big dent in the current surge. By late January, however, that could change. And it could be a harbinger of things to come in many countries around the world as they manage the bumpy transition to “living with the virus.”
New treatments like Paxlovid plus more vaccinations plus protection from previous infection could equal less strain on hospitals and a transition from a state of emergency to a long-term disease management approach to Covid.
Not every country will reach that point at the same time—emerging markets with low to moderate levels of vaccination and limited access to new treatments will once again be at the back of the line. And projections around this built-up wall of immunity have been proliferating for many months now, and they’ve been wrong every time (remember when Sweden was going to hit herd immunity in May 2020?). This time very well could be different. But surprises can’t be ruled out, as much as we all wish they could.
Could Omicron end up being a good thing?
It depends entirely on your time horizon.
In the short term, with hospitalizations still rising and all sorts of economic disruption mounting (e.g., massive flight cancellations), it’s hard to see this Omicron surge as anything but a bad thing.
In the medium term, it’s quite possible that this really does turn out to be the “exit wave” that we’ve discussed numerous times before, particularly for highly vaccinated countries. If Omicron is able to totally outcompete Delta (which remains uncertain) and turns out to be a much smaller threat to healthcare systems, then Omicron could ultimately be a good thing.
What would need to happen for the US to go back into strict lockdown?
A time machine to take us back to early 2020? A massive Ebola outbreak? Other than that, it’s hard to imagine most states going into anything resembling a strict lockdown.
At the peak of the US response in March/April 2020, even the strictest states only imposed “soft lockdowns” compared to what other countries did. In blue states, if you had parking lots filling up with very young Covid patients, you could imagine the return of indoor capacity restrictions, more mask mandates, hybrid education, etc. None of that really qualifies as a lockdown. China’s response to outbreaks qualifies as a lockdown.
Overall, pandemic fatigue is very high and the appetite for restrictions remains very low across much of the US. I don’t see that changing as we enter the third year of this pandemic.
Speaking of China, I’ve seen some data showing that even 3 doses of Sinovac might be ineffective against Omicron. What would this mean for China and for the global economy?
Sinovac does appear to be ineffective against infection. But it’s a difficult question to answer at this point because we still don’t have a great understanding of what that means for severe illness. Right now it’s probably safe to assume that these vaccines will be at least OK on this front but a little less OK than other vaccines on the market (similar to what we saw with Delta).
Even small differences in effectiveness would mean that countries that have been relying on Sinovac vaccines could see more explosive case spikes than those depending on mRNA vaccines (which are already seeing case spikes of their own due to reduced effectiveness against infection and transmission). This could once again strain hospitals in countries with already limited healthcare capacity (e.g., Indonesia). Many countries had already been diversifying away from Chinese vaccines for exactly this reason, and this data—if confirmed—will continue that trend.
In China, it means that the vaccines themselves won’t do much to stem a potential Omicron surge, meaning Beijing will continue to rely on its stringent “Zero Covid” strategy. This approach was always more focused on “NPIs” (non-pharmaceutical interventions), so Beijing will stick with that until it’s at least able to stock up on enough mRNA boosters and treatments like Paxlovid that can further reduce the risk of severe illness. That’s likely a number of months away. And the 20th Party Congress will convene in October 2022. Beijing has touted its Covid success as an example of its superior governance philosophy, so even small outbreaks before then are going to be seen as politically unacceptable, meaning risks of social and economic disruption in China—and therefore the global economy—will be with us for much of 2022.
🔔 And if you haven't already, don't forget to subscribe to my free newsletter, GZERO Daily by Ian Bremmer, to get new posts delivered to your inbox.
Key questions about the omicron variant
Ian Bremmer's Quick Take:
Good morning everybody and I hope everyone is okay this Monday. I hope you had a happy Thanksgiving, those of you that celebrate. Of course, pretty difficult news over the weekend, and even this morning, the World Health Organization, referring to the new variant omicron of COVID as a very high global risk. And when I hear those words, obviously we get moving at Eurasia Group, a firm very much concerned about that. And indeed, this is in terms of new news about this pandemic that we've all been living with now for almost two years, this is some of the most concerning new headlines that we've seen thus far.
There are some things we know and some things we don't know, there are three things we need to know, if you want to really assess what the omicron risk represents for us and for the world: rates of infection, sickness and mortality and vaccine effectiveness. We only have strong answers about the first, which is we know that this is a lot more infectious as a variant than Delta has been, which itself was much more infectious than the original virus. And that is a very serious problem. I've spoken with a lot of the epidemiologists we know about this over the weekend, they're all extremely concerned about that.
But we certainly don't know much at all about how lethal the disease is. For example, it could be that this disease is extremely infectious and less lethal than the delta variant. And if that was the case and it became the dominant variant, it would actually not just be a non-story, it would be extremely important and good news, because it would mean a whole bunch of people would be getting infected would be developing antibodies as a consequence and wouldn't be getting very sick, especially if it turns out that also didn't mean long COVID, which again, you're not going to know for quite some time. That's the problem with dealing with a disease that we've never heard of before.
But so far, the cases that we know about are overwhelmingly from South Africa and it's a population in terms of those that have tested positive that are mostly under 30, they don't have preexisting conditions and therefore they wouldn't be likely to get sick in any case. And so you're not learning anything. Turns out most of them still have sense of smell, that's a little unusual. Most of them more exhausted, have muscle pain, that's a little unusual, but nobody that's focusing on the cases that we have information on so far have a good sense. We probably won't have a good sense for about two more weeks.
Secondarily, the people making the vaccines feel pretty confident that these vaccines will be somewhat less effective than versus delta variants, simply because this variant is so different, but how less effective, they don't know. And they won't know that again for at least a couple of weeks. That's a problem too. So what we do know though, is that there is a relatively low level of vaccination still globally. There are plenty of places that have significant anti-vax and vaccine hesitancy sentiment, including my own United States, including Russia, including most of Eastern Europe. And there are also a lot of people that are immunocompromised, which means that even if this disease isn't a risk to you as a fully vaccinated person with a booster, it's still going to lead to lots of people getting hospitalized and dying, if it turns out that this is the same level of lethality as Delta.
So we'll find that out in relatively short order. And what that means is in the near-term, you're going to have a lot more risk aversion in travel. You're going to have a significant reduction in consumer demand. That'll take inflation off in the near term, it'll reduce prices at the pump for example. What happens over the next month to three depends completely on the answer to those two questions. And if this really is a dangerous, dominant global variant, as it well could be, it's kind of like a coin flip right now, then you're going to see all sorts of additional lockdowns, you'll see problems with supply chain, which will lead to more inflation again. It will be economic contraction and all of this will particularly be felt on the backs of poorer people and lower developed countries.
A big point here is that the mRNA vaccine producers, Pfizer, Moderna, can reformulate these vaccines to respond to Omicron variant within a matter of a few weeks. They can get them approved and then roll out major distribution in the course of a few months. So by end of first quarter next year, if you're in a wealthy country, you have access to mRNA vaccines, you'll be able once again, to protect yourself, protect your loved ones.
Having said that, the mRNA vaccines are available mostly to the wealthy countries. And this is yet one more accelerant of a big gap driving wedge between wealthy countries and poor countries. It's a big problem for China, which has to maintain their zero COVID policy. Maybe they can't even hold the Olympics. This is a bad scenario, they probably can't. They are trying to develop their own indigenous mRNA capabilities. They will have them at some point over the course, probably mid 2022, and then they will start producing and rolling them out. So again, bigger economic problems for China and particularly for those countries that aren't vaccinated yet that don't have the ability to get mRNA themselves. And also don't have the money to be able to respond to the economic scarring that occurs with all of these stop, start pandemic impact on the economy, they're going to be facing the absolute worst case scenarios here. And so that's the developing world, those are the emerging markets.
One final thing I would say here is Africa, there's a lot of people that are from South Africa that are very embittered by the fact that we're putting these travel restrictions on anyone from South Africa and a number of other countries of concern that of course are countries of concern in large part because they have virtually none of their population vaccinated, very low percentages. And in the case of South Africa, they do an awful lot of testing. They're pretty good at that. And that has allowed them to find out about the spread of the Omicron variant far earlier than we otherwise would've. So yes, they are being punished.
But what's really, horribly, both ironic and sad is that of the eight African countries that the Americans have put full travel restrictions on, five of them have actually refused recent additional exports of vaccines because they are worried about their existing stockpiles expiring. Why would that happen? Number one, too much vaccine hesitancy on the ground in those countries. Number two, too many difficulties in actually distributing the vaccines across countrysides that have very, very poor infrastructure indeed. So these countries are getting hit in every which way and just sending them vaccines by itself isn't going to fix the problem. We're going to need to do much more education on vaccinations. We're going to need to improve infrastructure and distribution capacity on the ground. Heck, in South Africa you have a huge immunocompromised population because of the AIDS epidemic, which is so large still there and in many countries in Sub-Saharan Africa, which means even if they take the vaccines, their body is not able to produce the kind of immunity, the kind of antibodies that would allow people to respond effectively and not get sick and die from COVID.
You remember Colin Powell who had suffered cancer and as a consequence had been taking drugs that really reduced his immune system. He was fully boosted and older and died from catching COVID. And there's really nothing we can do about that kind of thing until we stop spread and you're not going to stop spread until the entire global population is effectively vaccinated up to speed with full antibodies.
So that's where we are, not great news. Really hoping, as I'm sure everyone is, that we'll have better news over the course of the next couple weeks, as we learn much more about this new variant. Everyone be safe and I'll talk to you soon.
- What We're Watching: The Omicron variant sparks panic and ... ›
- The Graphic Truth: Who's refusing the COVID vaccine? - GZERO ... ›
- Make the COVID vaccine mandatory - GZERO Media ›
- What We're Watching: South Africa's COVID surge, the elusiveness ... ›
- Omicron variant unlikely to lead to lockdowns by governments - GZERO Media ›
- Omicron will be home for Christmas - GZERO Media ›
- Omicron will be home for Christmas - GZERO Media ›
Inflation is at 30-year highs. You can blame the pandemic for it.
Wondering why guac is extra extra at Chipotle these days? Afraid your milk consumption habits may not be financially sustainable? You can thank the highest inflation rate in thirty years.
If you think that sounds scary, you’re not alone. People seem to be losing their minds about it. No one likes to pay more for the same.
But while everyone has an opinion about this bout of inflation, almost no one really understands what’s causing it. And that’s critical to understanding a number of things, such as when it will go away, who’s hurting, what the government can do to make it better, and how it will affect President Biden politically.
Today’s post will look at the first two questions—what’s causing it and when it’ll go away. A second post tackles the rest.
A look at the numbers
According to the Bureau of Labor Statistics, consumer prices in the US were 0.94% higher in October than in September, rising 6.2% over the past year. After a decade of low inflation, this is the fastest 12-month pace since 1990 and the fifth consecutive month with inflation above 5%.
Want to understand the world a little better? Subscribe to GZERO Daily by Ian Bremmer for free and get new posts delivered to your inbox every week.
Part of this story can be explained by energy and food prices, which are up 30% over the last year globally. Despite what you might have heard, these have nothing to do with “Biden shutting down the Keystone XL pipeline” or levying a “Thanksgiving tax.” (Neither of those things exists.)
The truth is that oil and gas prices, which are set in international markets, have been climbing because of increased global demand as the world economy recovers from the pandemic. Fears about gas shortages across Europe and Asia ahead of the winter, combined with a slowdown in Chinese coal burning and OPEC+ oil producers’ refusal to increase supply by enough to meet the demand surge, have all contributed to the energy crunch.
Similarly, prices of food products traded internationally (including vegetable oils, cereals, sugar, meat, and dairy) have soared as high global demand has been met with supply constraints caused by the pandemic, extreme weather events, and political instability.
But core US inflation, which excludes energy and food prices, still rose 4.6% over the past year, the fastest pace since 1991. This has been driven by rising prices of goods, especially durable goods like cars, furniture, and appliances, which have increased by over 10%. In comparison, services prices are subdued and played no part in inflation over the last year (although they have been picking up since April on the back of an improving public health situation).
Blame lies with the pandemic, not policy
Conservative pundits have been flooding the airwaves claiming the Biden administration stoked inflation by injecting too much stimulus into the economy, causing there to be “too much money chasing too few goods.” Does that mean that inflation is the result of bad policy?
The data says no.
When the pandemic hit, large parts of the economy were forced to shut down. The virus disrupted every activity that required in-person interaction, including manufacturing operations, services like gyms, restaurants, travel, schools, etc., and jobs that couldn’t be done remotely. Lots of businesses were shuttered, millions lost their jobs.
The US government responded by giving people and businesses a ton of money to pay their bills, avert mass bankruptcies, and prevent another Great Depression. This was smart, and wildly successful. Poverty actually declined, disposable income and household saving increased to record-highs, and asset prices boomed.
Because they couldn’t spend the extra cash on things like haircuts, travel, or restaurants, Americans turned to at-home consumption, ordering everything from gym equipment and office furniture to loungewear and gardening tools. In other words, the government’s necessary and successful response to Covid amid pandemic lockdowns triggered a consumption boom that saw demand for goods rise way above pre-pandemic levels—even though millions of jobs had just been destroyed.
Consumer spending has been uneven since the pandemicFederal Reseve Bank of St. Louis
Awash in new orders, global supply couldn’t keep up. Not only had Covid disrupted manufacturing, logistics, and distribution operations, but every link in the chain had braced for a prolonged slump.
Global supply chains are deliberately designed to be lean, prioritizing efficiency over resilience. Usually it works well, but when (for whatever reason) demand exceeds normal supply levels, they have no spare capacity. As a result, rather than increase output and employment, additional spending causes prices to rise.
That’s exactly what happened in the face of what was a historically unprecedented, and wholly unexpected, surge in demand for goods. The mismatch between Americans’ voracious appetite for stuff and the world’s ability to sate it manifested in shortages, soaring costs, and rising prices. The bottlenecks showed up throughout the supply chain, from raw materials and intermediate goods to freight transport and warehousing. Snarls upstream caused shortages downstream, increasing costs and prices along the way.
Will US kids get their toys on time?Institute for Supply Management, Case Statista, GZREO Media
When vaccines rolled out and economic activity picked up, labor demand boomed and previously unemployed workers started coming back from the sidelines, boosting demand even further. But not everyone came back. Some workers retired early or left the workforce to care for their children. A few decided to hold out for better opportunities and could now afford to because of the pandemic relief. Most importantly, a record number of predominantly low-wage workers began quitting their jobs en masse, encouraged by the highest-ever job opening rate on record.
The effect of this “Great Resignation” has been a labor shortage, concentrated in low-paying occupations, that is forcing employers to finally compete for workers. In turn, this increase in labor costs has been passed on to consumers in the form of higher prices.
To recap:
- Rising food and energy costs, including gas prices at the pump, are a global phenomenon caused by the pandemic and its global aftereffects.
- The policy response to the pandemic was appropriate and effective at sustaining aggregate spending and preventing a lot of unnecessary suffering. While the economy is doing well, it is by no means overheating, as evidenced by the fact that GDP is still 2.6% below its pre-pandemic trend and employment hasn’t fully recovered.
- Rising prices of goods are a direct result of the pandemic, which shifted the composition of spending away from services and toward goods, destroyed productive capacity, disrupted supply chains, and reallocated labor.
- Inflation is being exacerbated by bottlenecks that were waiting to happen, predating the pandemic but triggered by it. For example, the ground shipping industry had been lowering trucker pay and eroding worker protections for decades. Now there’s a massive trucker shortage preventing goods from moving from ports to warehouses to retailers to your doorstep.
- Taking the pandemic’s effects on consumption patterns and supply chains as well as the latent vulnerabilities in our just-in-time mode of production as given, high inflation was the price to pay to prevent suffering on a scale not seen since the Great Depression. No alternative policy response could’ve gotten the best of both worlds.
Let's see who this really is... |
The story is roughly the same outside the US. Last month, consumer prices jumped 1.1% in Britain and 0.7% in Europe. Even Germany, which unlike the US didn’t respond to the pandemic with large-scale fiscal stimulus, has seen inflation rise to 4.6% over the past year. If this doesn’t convince you that inflation is mainly about the global pandemic rather than US policy choices, I guess nothing will.
When will inflation let up?
The jury is still out on this one.
There are a few reasons why inflation could in theory remain elevated for a while. A strong labor market, still-high disposable incomes, and accommodative monetary policy could continue to sustain high demand. The price of services like travel, hospitality, and restaurants will accelerate as booster shots encourage people to go out. Supply chains may take some time to return to normal, given how sticky they have been. The great resignation could persist, making labor scarcer and putting upward pressure on wages. If inflationary expectations set in, workers might demand higher pay to keep up and consumers may start to frontload spending, in turn accelerating wage and price inflation… Again, not implausible.
But there are also compelling reasons to think inflation will come down on its own soon, as the factors that caused it begin to ease. The bulk of the fiscal response to the pandemic is over, so spending levels will return to normal. As the pandemic abates and the economy reopens fully, consumption will swing back toward services and away from goods, workers will return to work, and supply chains will untangle. Once Covid treatments and vaccines are available everywhere, new outbreaks will stop causing supply disruptions and unbalanced demand.
Shipping costs are recedingStatista
We are already seeing these dynamics play out in the data. Consumption patterns are shifting back towards services, with durable goods expenditures falling by 8% since April and inventories surging. Bottlenecks are starting to unwind, with the Baltic Dry Index, a measure of global shipping rates, plunging 50% since October. Container traffic at the Port of Los Angeles is down 30%. The International Energy Agency says oil prices are about to peak.
On balance, the evidence suggests inflation will come down gradually over the next year. The trillion-dollar question is what happens in the meantime. Read my next post to find out.
🔔 And if you haven't already, don't forget to subscribe to my free newsletter, GZERO Daily by Ian Bremmer, to get new posts delivered to your inbox.